Idelalisib Nitroso Impurity 3 - Request Quote
Idelalisib Nitroso Impurity 3
| SZ CAT No: | SZ-I034011 |
| CAS No | NA |
| Mol.F. | C22H17FN8O2 |
| Mol.Wt. | 444.4 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Idelalisib Nitroso Impurity 3 is chemically (S)-5-Fluoro-2-(1-((7-nitroso-7H-purin-6-yl)amino)propyl)-3-phenylquinazolin-4(3H)-one. Idelalisib Nitroso Impurity 3 is supplied with detailed characterization data compliant with regulatory guideline. Idelalisib Nitroso Impurity 3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Idelalisib .
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Idelalisib Nitroso Impurity 3
Purchase Idelalisib Nitroso Impurity 3
Idelalisib Nitroso Impurity 3 suppliers
Idelalisib Nitroso Impurity 3 manufacturers
Idelalisib Nitroso Impurity 3 price
Order Idelalisib Nitroso Impurity 3
Enquire Idelalisib Nitroso Impurity 3
Idelalisib Nitroso Impurity 3 cost
Idelalisib Nitroso Impurity 3 Supplier
Idelalisib Nitroso Impurity 3 Distributor
Idelalisib Nitroso Impurity 3 for Method Validation
Idelalisib Reference Standard
Idelalisib Nitroso Impurity 3 for ANDA Filing
Idelalisib Nitroso Impurity 3 for Forced Degradation Studies
Idelalisib Nitroso Impurity 3 Identification Standards
Idelalisib Nitroso Impurity 3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


